Effects of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes and an Inhibitor of OATP1B1/3 Transport, on the Single Dose Pharmacokinetics of Anacetrapib-Reference-Cited by-同舟云学术

Effects of Rifampin, a Potent Inducer of Drug-Metabolizing Enzymes and an Inhibitor of OATP1B1/3 Transport, on the Single Dose Pharmacokinetics of Anacetrapib

Published:2013-05-14 Issue:7 Volume:53 Page:746-752
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharmacology

Author:

Anderson Matt S.¹,Cote Josee¹,Liu Yang¹,Stypinski Daria²,Auger Patrice²,Hohnstein Anne²,Rasmussen Scott²,Johnson-Levonas Amy O.¹,Gutstein David E.¹

Affiliation:

1. Merck Sharp & Dohme Corp.; Whitehouse Station; NJ; USA

2. Celerion; Lincoln; NE; USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jcph.97/fullpdf

Reference7 articles.

1. Assessment of the CYP3A-mediated drug interaction potential of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy volunteers;Krishna;J Clin Pharmacol.,2009

2. Lack of an effect of anacetrapib on the pharmacokinetics of digoxin in healthy subjects;Krishna;Biopharm Drug Dispos.,2011

3. Inhibitory effects of ketoconazole and rifampin on OAT1 and OATP1B1 transport activities: considerations on drug-drug interactions;Choi;Biopharm Drug Dispos.,2011

4. Rifampin's acute inhibitory and chronic inductive drug interactions: experimental and model-based approaches to drug-drug interaction trial design;Reitman;Clin Pharmacol Ther.,2011

5. Multiple-dose pharmacodynamics and pharmacokinetics of anacetrapib, a potent cholesteryl ester transfer protein (CETP) inhibitor, in healthy subjects;Krishna;Clin Pharmacol Ther.,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanistic Account of Distinct Change in Organic Anion Transporting Polypeptide 1B (OATP1B) Substrate Pharmacokinetics during OATP1B-Mediated Drug-Drug Interactions Using Physiologically Based Pharmacokinetic Modeling;Drug Metabolism and Disposition;2024-05-13

2. Therapeutic Potential of Morin Hydrate Against Rifampicin Induced Hepato and Renotoxicity in Albino Wistar Rats: Modulation of Organ Function, Oxidative Stress and Inflammatory Response;Indian Journal of Clinical Biochemistry;2023-08-04

3. Pharmacokinetics, Safety and Tolerability of Anacetrapib, a Novel Cholesteryl Ester Transfer Protein (CETP) Inhibitor, After Single and Multiple Doses in Healthy Chinese Subjects;Advances in Therapy;2021-06-08

4. Telfairia occidentalis (Cucurbitaceae) pulp extract mitigates rifampicin-isoniazid-induced hepatotoxicity in an in vivo rat model of oxidative stress;Journal of Integrative Medicine;2019-01

5. Pharmacokinetics and Pharmacodynamics of Anacetrapib in Black and White Healthy Subjects;The Journal of Clinical Pharmacology;2018-07-20